‘In a timely manner’? If so, it would have been approved years ago… such a joke
- Forums
- ASX - By Stock
- MYX
- Ann: MAYNE PHARMA provides FDA update on generic NUVARING
MYX
mayne pharma group limited
Add to My Watchlist
0.19%
!
$5.26

Ann: MAYNE PHARMA provides FDA update on generic NUVARING, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.26 |
Change
0.010(0.19%) |
Mkt cap ! $430.6M |
Open | High | Low | Value | Volume |
$5.25 | $5.30 | $5.25 | $260.4K | 49.19K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1 | $5.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.28 | 3405 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1475 | 5.280 |
2 | 802 | 5.270 |
4 | 3305 | 5.260 |
6 | 10575 | 5.250 |
3 | 3222 | 5.240 |
Price($) | Vol. | No. |
---|---|---|
5.300 | 3627 | 6 |
5.310 | 3888 | 6 |
5.320 | 1652 | 4 |
5.330 | 1354 | 3 |
5.340 | 1354 | 3 |
Last trade - 10.55am 28/07/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online